Transmucosal Absorption Enhancers in the Drug Delivery Field.
absorption modifying excipients
nasal delivery
ocular delivery
oral delivery
permeation enhancers
transmucosal permeation
vaginal delivery
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
15 Jul 2019
15 Jul 2019
Historique:
received:
10
07
2019
accepted:
11
07
2019
entrez:
18
7
2019
pubmed:
18
7
2019
medline:
18
7
2019
Statut:
epublish
Résumé
Drug delivery systems that safely and consistently improve transport of poorly absorbed compounds across epithelial barriers are highly sought within the drug delivery field. The use of chemical permeation enhancers is one of the simplest and widely tested approaches to improve transmucosal permeability via oral, nasal, buccal, ocular and pulmonary routes. To date, only a small number of permeation enhancers have progressed to clinical trials, and only one product that includes a permeation enhancer has reached the pharmaceutical market. This editorial is an introduction to the special issue entitled
Identifiants
pubmed: 31311173
pii: pharmaceutics11070339
doi: 10.3390/pharmaceutics11070339
pmc: PMC6680553
pii:
doi:
Types de publication
Editorial
Langues
eng
Déclaration de conflit d'intérêts
Lisbeth Illum was Chief Executive Officer of Critical Pharmaceuticals Ltd (Nottingham, UK) until the end of 2011.
Références
Adv Drug Deliv Rev. 1999 Mar 1;36(1):41-57
pubmed: 10837708
Adv Drug Deliv Rev. 2004 Apr 19;56(6):795-807
pubmed: 15063590
J Pharm Pharmacol. 2005 Jun;57(6):681-7
pubmed: 15969922
Expert Opin Drug Deliv. 2006 Jul;3(4):529-39
pubmed: 16822227
J Control Release. 2007 Sep 26;122(2):141-50
pubmed: 17707540
Eur J Pharm Sci. 2009 Apr 11;37(1):36-42
pubmed: 19162181
J Diabetes Sci Technol. 2008 May;2(3):518-29
pubmed: 19885220
Ann N Y Acad Sci. 2010 Jun;1199:69-76
pubmed: 20633110
J Clin Pharmacol. 2011 Apr;51(4):460-71
pubmed: 20660294
Ther Deliv. 2013 Mar;4(3):315-26
pubmed: 23442079
Pharm Res. 2015 Feb;32(2):516-27
pubmed: 25190006
Br J Clin Pharmacol. 2015 May;79(5):720-32
pubmed: 25408230
Ther Deliv. 2015 Feb;6(2):149-63
pubmed: 25690084
Drug Deliv Transl Res. 2013 Feb;3(1):26-32
pubmed: 25787865
J Clin Endocrinol Metab. 2015 Nov;100(11):4364-71
pubmed: 26425883
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt B):223-241
pubmed: 26921819
Int J Pharm. 2016 Apr 30;503(1-2):127-40
pubmed: 26924357
Int J Pharm. 2016 May 17;504(1-2):59-69
pubmed: 26976502
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt B):277-319
pubmed: 27320643
Tissue Barriers. 2016 Apr 18;4(2):e1178369
pubmed: 27358757
Chem Rev. 2017 Jun 28;117(12):8094-8128
pubmed: 28541045
Int J Pharm. 2018 Jan 15;535(1-2):113-119
pubmed: 29038066
JAMA. 2017 Oct 17;318(15):1460-1470
pubmed: 29049653
Angew Chem Int Ed Engl. 2018 Apr 9;57(16):4156-4163
pubmed: 29520902
J Control Release. 2018 Jun 10;279:208-219
pubmed: 29614254
Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7296-7301
pubmed: 29941553
Pharmaceutics. 2018 Jul 03;10(3):null
pubmed: 29970849
Pharmaceutics. 2018 Oct 02;10(4):null
pubmed: 30279382
Pharmaceutics. 2018 Oct 10;10(4):null
pubmed: 30308982
Int J Pharm. 2018 Dec 20;553(1-2):8-20
pubmed: 30316796
Pharmaceutics. 2018 Oct 26;10(4):null
pubmed: 30373187
Pharmaceutics. 2018 Nov 05;10(4):null
pubmed: 30400577
Sci Transl Med. 2018 Nov 14;10(467):null
pubmed: 30429357
Pharmaceutics. 2018 Nov 20;10(4):null
pubmed: 30463361
Pharmaceutics. 2019 Jan 04;11(1):null
pubmed: 30621141
Pharmaceutics. 2019 Jan 16;11(1):null
pubmed: 30654429
Pharmaceutics. 2019 Jan 18;11(1):null
pubmed: 30669246
Pharmaceutics. 2019 Jan 19;11(1):null
pubmed: 30669434
Lancet Diabetes Endocrinol. 2019 Mar;7(3):162-163
pubmed: 30679094
Lancet Diabetes Endocrinol. 2019 Mar;7(3):179-188
pubmed: 30679095
Pharmaceutics. 2019 Feb 09;11(2):null
pubmed: 30744102
Pharmaceutics. 2019 Feb 10;11(2):null
pubmed: 30744154
Pharmaceutics. 2019 Feb 18;11(2):null
pubmed: 30781722
Pharmaceutics. 2019 Feb 13;11(2):null
pubmed: 30781867
Pharmaceutics. 2019 Mar 11;11(3):null
pubmed: 30861990
Pharmaceutics. 2019 Apr 07;11(4):null
pubmed: 30959978
Front Endocrinol (Lausanne). 2019 Apr 12;10:155
pubmed: 31031702
Pharmaceutics. 2019 Jun 26;11(7):null
pubmed: 31248025
Pharmaceutics. 2019 Jul 09;11(7):null
pubmed: 31324063